Treat Chronic Lymphedema: The Effects of Apigenin, Diosmetin, and Chicoric Acid on TNF-Alpha and COX-2 Levels of Stimulated RAW 264.7 Macrophages
Overview
Lymphedema is chronic, progressive and potentially disabling, characterized by regional bodily swelling and accumulation of protein-rich interstitial fluid. It affects over 100 million people worldwide. Lymphedema causes chronic cutaneous inflammation, attracting phagocytic macrophages to the region. Poor tissue conditions created by impaired circulation and stagnant interstitial fluid depress macrophage activity. There is no pharmacological or curative treatment for lymphedema. This in-vitro experiment was conducted to develop a first natural pharmaceutical to treat chronic lymphedema by determining the anti-inflammatory and immune-modulating effects of apigenin, diosmetin, and chicoric acid when applied to stimulated RAW 264.7 murine macrophages, measuring Tumour Necrosing Factor alpha (TNFa) and Cyclooxygenase-2 (COX-2). After a 48-hour exposure, all reagents demonstrated an immune-stimulating effect, shown by an increase in TNFa. Diosmetin caused a significant immune-stimulating effect, with TNFa levels above the “High LPS Stimulation” control. The role of lymphangiogenesis in the setting of lymphedema is a prime area of investigation. An experiment with mouse tail models of lymphedema revealed that an inhibition of COX-2, along with a paradoxical stimulation of TNFa (and correlated rise in VEGF-C), reduced lymphedema, improving the lymphatic circulatory insufficiency associated with inflammation. Therefore, this experiment was undertaken to find a natural reagent that would stimulate macrophage TNFa expression while influencing COX-2 expression. All reagents showed potential; however, diosmetin’s significant ability to enhance TNFa in this experiment demonstrates the promise of a future breakthrough in developing a drug to treat chronic lymphedema.
Competition history
- ISEF 2014
Resources
Related projects
ISEF · 2015
The Pharmacological Potential of Apigenin and Diosmetin as a Novel Treatment for Chronic Lymphedema
ISEF · 2018
Inhibition of LPS-Induced Inflammation in Macrophages Through Natural Anti-Inflammatory Compounds
ISEF · 2021
Anti-inflammatory Effects of the Biflavonoid Biflata on Macrophage
JSHS · 2024
Immunomodulatory Response of Neem Leaves Extract and its use in Treating Chronic Inflammatory Diseases
ISEF · 2025
Unveiling Synergistic Anti-Inflammatory Effects of Neem Leaf Bioactives: A Low-Cost, Eco-Friendly Breakthrough for Sustainable Disease Treatment
ISEF · 2017
Harnessing Anti-Inflammatory and Immunomodulatory Potentials from Nature for Cancer Therapy
ISEF · 2015
Modulation of Macrophage Phenotype Using Nanoparticle-Delivered Gene Therapy for Treatment of Inflammatory Diseases
ISEF · 2025
Combating Inflammatory Disease: Anti-inflammatory Effect of Nisin (Bacteriocin) on Lipopolysaccharide-stimulated THP-1 Cell
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair